BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2012
View Archived Issues
Advanced Cancer Therapeutics receives NIH grant to develop novel agent for brain cancer
Read More
Specialised Therapeutics Australia in-licenses rights to anamorelin
Read More
Probiodrug discloses novel glutaminyl cyclase inhibitors
Read More
Chinese researchers disclose new PAF acetylhydrolase inhibitors
Read More
Eternity Bioscience patents novel PARP-1 inhibitors
Read More
Teijin Pharma presents novel CaSR antagonists with promising in vivo activity
Read More
NKTR-171 demonstrates efficacy in animal models of neuropathic pain
Read More
Grindeks discloses single enantiomer for cognitive disorders
Read More
Eli Lilly reports phase III data for ramucirumab in gastric cancer
Read More
New CCR2 receptor antagonists presented by Merck & Co.
Read More
Octahydrogenacridine succinate shows promising pharmacokinetics in healthy Chinese subjects
Read More
Idera Pharmaceuticals completes patient enrollment in phase II IMO-3100 trial
Read More
Researchers at Reata Pharmaceuticals prepare new NO production inhibitors
Read More
FDA accepts Serada NDA for filing
Read More
FDA grants Meridian Laboratories pre-IND meeting for ML-061
Read More
Tasimelteon restores cortisol rhythms in blind patients
Read More
Enrollment of fifth patient in ibrutinib trial triggers milestone payment
Read More
Novavax begins phase I trial of RSV vaccine candidate in older subjects
Read More
Endoribonuclease Dicer may be a marker for multiple sclerosis
Read More
Novo Nordisk submits U.S. and E.U. applications for turoctocog alfa
Read More
BioDelivery Sciences will launch Breakyl in the E.U.
Read More
FDA approves expanded indication for Actemra
Read More
Onyx Pharmaceuticals completes enrollment in phase III FOCUS trial
Read More
Abbott discloses initial results from phase IIb study of interferon-free HCV treatment regimen
Read More